ClinicalTrials.Veeva

Menu

Blood and Urine Sample Collection From Healthy Volunteers

E

Evotec

Status

Completed

Conditions

Healthy

Study type

Observational

Funder types

Industry

Identifiers

NCT05154409
EVT_CTC_01

Details and patient eligibility

About

The aim of the study is to obtain blood and urine samples from healthy volunteers to serve as a healthy control group for cross-cohort comparisons.

Full description

The aim of the study is to obtain peripheral venous blood samples and a urine sample from 100 healthy volunteers on one day at three different times of the day, to serve as a healthy control group for cross-cohort comparisons.

With the help of the urine and blood samples obtained in this context, a cohort of a healthy collective is to be established for further research purposes.

Enrollment

100 patients

Sex

All

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male and female subjects aged 40-70 years.
  • Caucasian
  • Non-smokers or ex-smokers
  • Body Mass Index (BMI): ≥18.5 and ≤32 kg/m2
  • Presence of a negative SARS-CoV-2 PCR test.

Exclusion criteria

  • Complaints that may indicate the presence of an infection, including Covid-19.
  • Pathological alcohol consumption.
  • Positive alcohol breath test at the preliminary examination.
  • Alcohol consumption within the last 24 hours before the start of sampling.
  • History of drug dependence.
  • Positive urine drug test during the preliminary examination.
  • Clinically significant acute or chronic disease. In particular, chronic inflammation, rheumatological and other autoimmune diseases, diabetes and other metabolic diseases.
  • Indications in the medical history or during the medical examination that may jeopardize the safety of the study participant by participating in the study.
  • History of relevant clinically significant cardiovascular disorders or clinically relevant hyper- or hypotension or clinically relevant brady- or tachycardia at screening as assessed by an investigator.
  • Heart rate <45/min after 5 minutes in a quiet sitting position.
  • Heart rate >100/min after 5 minutes in a quiet sitting position.
  • Systolic blood pressure of > 170 mmHg or < 90 mmHg.
  • Diastolic blood pressure of > 95 mmHg and/or < 60 mmHg.
  • Regular use of prescription medication within 3 months prior to inclusion in the research project.
  • Use of non-prescription medications within 3 days prior to inclusion in the research project.
  • Presence of clinically significant food intolerance and/or food allergy as assessed by the investigator.
  • Medically relevant previous operations.
  • Condition following radio- or chemotherapy.
  • History of oncological diseases.
  • Blood and/or plasma donation within the last 30 days prior to sample collection.
  • Pregnant or nursing female.
  • Employees of study site.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems